FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 309:340-344 August 11, 1983 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Protein C is the zymogen of a vitamin K-dependent serine protease involved in blood coagulation. In the absence of protein C the inactivation of activated factors V and VIIIC is impaired, and the fibrinolytic capacity of the circulating blood is reduced. These conditions promote excessive fibrin formation and thus constitute a risk factor for thrombosis. Using an immunologic assay for protein C, we identified 18 patients (11 male and 7 female) in three unrelated Dutch families as fulfilling the criteria for an isolated protein C deficiency. In 12 patients who were not receiving oral anticoagulant treatment the mean protein C antigen concentration was 0.48 +/- 0.09 U per milliliter (+/- S.D.), and in 6 patients who were receiving adjusted doses of oral anticoagulants and had stable anticoagulation, the mean value was 0.17 +/- 0.05 U per milliliter. (The value in healthy subjects is 0.98 +/- 0.19 U per milliliter.) Fourteen of the 18 patients had a history of venous thromboembolism, with superficial thrombophlebitis as the hallmark of this condition (in 13 patients). These data are consistent with an autosomal dominant trait with variable expressivity.

This article has been cited by other articles:

• Buyru, N., Altinisik, J., Somay, G., Ulutin, T. (2005). Factor V Leiden Mutation in Cerebrovascular Disease. CLIN APPL THROMB HEMOST 11: 339-342 [Abstract]  
• Berg, D. T., Gerlitz, B., Shang, J., Smith, T., Santa, P., Richardson, M. A., Kurz, K. D., Grinnell, B. W., Mace, K., Jones, B. E. (2003). Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc. Natl. Acad. Sci. USA 100: 4423-4428 [Abstract] [Full Text]  
• Thomas, R. H. (2001). Hypercoagulability Syndromes. Arch Intern Med 161: 2433-2439 [Abstract] [Full Text]  
• Eldridge, J., Dilley, A., Austin, H., EL-Jamil, M., Wolstein, L., Doris, J., Hooper, W. C., Meehan, P. L., Evatt, B. (2001). The Role of Protein C, Protein S, and Resistance to Activated Protein C in Legg-Perthes Disease. Pediatrics 107: 1329-1334 [Abstract] [Full Text]  
• Matitiau, A., Tabachnik, E., Sthoeger, D., Birk, E. (2001). Thrombus in the Left Ventricle of a Child With Systemic Emboli: An Unusual Presentation of Hereditary Protein C Deficiency. Pediatrics 107: 421-422 [Abstract] [Full Text]  
• Inoue, A., Wada, H., Takagi, M., Yamamuro, M., Mukai, K., Nakasaki, T., Shimura, M., Hiyoyama, K., Deguchi, H., Gabazza, E. C., Mori, Y., Nishikawa, M., Deguchi, K., Shiku, H. (2000). Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis. CLIN APPL THROMB HEMOST 6: 100-103 [Abstract]  
• Sanson, B.-J., Simioni, P., Tormene, D., Moia, M., Friederich, P. W., Huisman, M. V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P. M., Girolami, A., Buller, H. R., Prins, M. H. (1999). The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study. Blood 94: 3702-3706 [Abstract] [Full Text]  
• Butenas, S., van't Veer, C., Mann, K. G. (1999). "Normal" Thrombin Generation. Blood 94: 2169-2178 [Abstract] [Full Text]  
• Takagi, M., Wada, H., Mukai, K., Minamikawa, K., Wakita, Y., Deguchi, K., Junji, N., Hayashi, T., Suzuki, K., Shiku, H. (1999). State-of-the-Art Review : Increased Activated Protein C: Protein C Inhibitor Complex and Decreased Protein C Inhibitor Levels in Patients with Chronic Renal Failure on Maintenance Hemodialysis. CLIN APPL THROMB HEMOST 5: 113-116 [Abstract]  
• deVeber, G., Monagle, P., Chan, A., MacGregor, D., Curtis, R., Lee, S., Vegh, P., Adams, M., Marzinotto, V., Leaker, M., Massicotte, M. P., Lillicrap, D., Andrew, M. (1998). Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism. Arch Neurol 55: 1539-1543 [Abstract] [Full Text]  
• Spek, C. A., Lannoy, V. J., Lemaigre, F. P., Rousseau, G. G., Bertina, R. M., Reitsma, P. H. (1998). Type I Protein C Deficiency Caused by Disruption of a Hepatocyte Nuclear Factor (HNF)-6/HNF-1 Binding Site in the Human Protein C Gene Promoter. J. Biol. Chem. 273: 10168-10173 [Abstract] [Full Text]  
• Bick, R. L., Kaplan, H. (1998). Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias. CLIN APPL THROMB HEMOST 4: 25-50 [Abstract]  
• Pak, H. D., Perrotta, A. L. (1997). Venous Thromboembolism in Heterozygotes for Factor V Leiden The Second-Hit Hypothesis: A Report of Two Patients and a Review of the English-Language Literature. CLIN APPL THROMB HEMOST 3: 210-212 [Abstract]  
• van den Belt, A. G. M., Prins, M. H., Huisman, M. V., Hirsh, J. (1996). Familial Thrombophilia: A Review Analysis. CLIN APPL THROMB HEMOST 2: 227-236 [Abstract]  
• Hirsh, J., Hoak, J. (1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation 93: 2212-2245 [Full Text]  
• Spek, C. A., Greengard, J. S., Griffin, J. H., Bertina, R. M., Reitsma, P. H. (1995). Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites. J. Biol. Chem. 270: 24216-24221 [Abstract] [Full Text]  
• Allaart, C F, Rosendaal, F R, Noteboom, W M P, Vandenbroucke, J P, Briet, E (1995). Survival in families with hereditary protein C deficiency, 1820 to 1993. BMJ 311: 910-912 [Abstract] [Full Text]  
• Kroshus, T. J., Kshettry, V. R., Hertz, M. I., Bolman, R. M. III (1995). DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM AFTER LUNG TRANSPLANTATION. J. Thorac. Cardiovasc. Surg. 110: 540-544 [Abstract] [Full Text]  
• Spek, C. A., Koster, T., Rosendaal, F. R., Bertina, R. M., Reitsma, P. H. (1995). Genotypic Variation in the Promoter Region of the Protein C Gene Is Associated With Plasma Protein C Levels and Thrombotic Risk. Arterioscler. Thromb. Vasc. Bio. 15: 214-218 [Abstract] [Full Text]  
• Doig, R. G., Begley, C. G., McGrath, K. M. (1995). Hereditary Protein C Deficiency: The Australian Experience. CLIN APPL THROMB HEMOST 1: 49-54 [Abstract]  
• Bayraktar, Y., Balkanci, F., Kansu, E., Kayhan, B., Arslan, S., Eryilmaz, M., Telatar, H. (1993). Budd-Chiari Syndrome: Analysis of 30 Cases. ANGIOLOGY 44: 541-551 [Abstract]  
• Simioni, P., Zanon, G., Lazzaro, A.R., Patrassi, G.M., Girolami, A. (1991). Heterozygous Protein C Deficiency Associated with Multiple Congenital Hemangiomas A Case Report. ANGIOLOGY 42: 337-342 [Abstract]  
• Cohen, D. J., Briggs, R., Head, H. D., Acher, C. W. (1989). Phlegmasia Cerulea Dolens and Its Association with Hypercoagulable States: Case Reports. ANGIOLOGY 40: 498-508 [Abstract]  
• Esmon, C. (1987). The regulation of natural anticoagulant pathways. Science 235: 1348-1352 [Abstract]  
• Rezaie, A. R. (2001). Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1. IMPLICATIONS FOR THE MECHANISM OF PROFIBRINOLYTIC ACTION OF ACTIVATED PROTEIN C. J. Biol. Chem. 276: 15567-15570 [Abstract] [Full Text]